These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 41176)

  • 1. The development of anti-allergic drugs.
    Orr TS
    Monogr Allergy; 1979; 14():293-8. PubMed ID: 41176
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-allergic properties of a new coumarin compound (BM 15,100) [proceedings].
    Roesch A; Roesch E
    Br J Pharmacol; 1976 Jul; 57(3):438P. PubMed ID: 10033
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiallergic activity of picumast dihydrochloride in several animal species.
    Roesch A; Schaumann W; Wilhelms OH
    Arzneimittelforschung; 1989 Oct; 39(10A):1310-6. PubMed ID: 2576354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of allergic reactions by a novel phenanthroline ICI 74,917.
    Evans DP; Gilman DJ; Thomson DS; Waring WS
    Nature; 1974 Aug; 250(467):592-3. PubMed ID: 4136035
    [No Abstract]   [Full Text] [Related]  

  • 6. Picumast dihydrochloride (Auteral), a new anti-allergic inhibitor of mediator release and action.
    Wilhelms OH; Roesch A; Schaumann W
    Agents Actions Suppl; 1991; 34():335-49. PubMed ID: 1686528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunopharmacological studies of anti-hypersensitivity agents].
    Koda A
    Nihon Rinsho; 1981 Apr; 39(4):1801-6. PubMed ID: 6171654
    [No Abstract]   [Full Text] [Related]  

  • 9. Nature and modes of action of disodium cromoglycate (Lomudal).
    Cox JS; Altounyan RE
    Respiration; 1970; 27():Suppl:292-309. PubMed ID: 4101895
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
    De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
    Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiallergic properties of SQ 13,847, an orally effective agent. I. Activity in vivo.
    Casey FB; Abboa-Offei BE; Marretta J
    J Pharmacol Exp Ther; 1980 Jun; 213(3):432-6. PubMed ID: 7205610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of disodium cromoglycate on various types of anaphylactic reaction in the guinea pig.
    Taylor WA; Roitt IM
    Int Arch Allergy Appl Immunol; 1973; 45(6):795-807. PubMed ID: 4128404
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
    Rosenthale ME; Begany AJ; Dervinis A; Sellstedt J; Guinosso C; Gluckman MI
    J Pharmacol Exp Ther; 1976 Jun; 197(3):725-33. PubMed ID: 58988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses.
    Lever R; Hefni A; Moffatt JD; Paul W; Page CP
    Clin Exp Allergy; 2007 Jun; 37(6):909-17. PubMed ID: 17517105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs used in allergic states and their mode of action.
    Eisner JW
    Semin Drug Treat; 1973; 2(4):367-77. PubMed ID: 4122217
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacology of allergic eye disease.
    Bartlett JD
    J Am Optom Assoc; 1990 Jun; 61(6 Suppl):S23-31. PubMed ID: 1972944
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of various anti-allergic agents on IgE-mediated anaphylactic alterations of pulmonary function in rats.
    Menassé R; Ferrini PG; Niderhauser U; Szeszak J
    Monogr Allergy; 1979; 14():126-9. PubMed ID: 116122
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cromoglycate disodium in vasomotoric rhinopathies, not specifically allergic, of the perennial type].
    Volterrani O
    Folia Allergol (Roma); 1972; 19(2):171-3. PubMed ID: 4402876
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.